{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:43:42Z","timestamp":1790145822150,"version":"4.0.1"},"reference-count":110,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.mcna.2009.02.010","type":"journal-article","created":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T08:40:56Z","timestamp":1241772056000},"page":"733-751","source":"Crossref","is-referenced-by-count":99,"title":["Obesity and Hypertension: Mechanisms, Cardio-Renal Consequences, and Therapeutic Approaches"],"prefix":"10.1016","volume":"93","author":[{"given":"Efrain","family":"Reisin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avanelle V.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mcna.2009.02.010_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1742-1241.2006.01262.x","article-title":"Obesity-hypertension: an ongoing pandemic","volume":"61","author":"Francischetti","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"13","key":"10.1016\/j.mcna.2009.02.010_bib2","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999\u20132004","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcna.2009.02.010_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.HYP.0000252676.46043.18","article-title":"Prevalence, awareness, treatment, and control of hypertension among United States adults 1999\u20132004","volume":"49","author":"Ong","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.mcna.2009.02.010_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/08037050701715117","article-title":"Undiagnosed obesity in hypertension: clinical and therapeutic implications","volume":"16","author":"Romero","year":"2007","journal-title":"Blood Press"},{"issue":"3","key":"10.1016\/j.mcna.2009.02.010_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1467-789X.2006.00292.x","article-title":"The burden of overweight and obesity in the Asia-Pacific region","volume":"8","year":"2007","journal-title":"Obes Rev"},{"issue":"2","key":"10.1016\/j.mcna.2009.02.010_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/HJH.0b013e3282f16ad3","article-title":"Is central obesity a better discriminator of the risk of hypertension than body mass index in ethnically diverse populations?","volume":"26","year":"2008","journal-title":"J\u00a0Hypertens"},{"issue":"2","key":"10.1016\/j.mcna.2009.02.010_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11906-008-0028-8","article-title":"Mechanisms underlying obesity associated with systemic and renal hemodynamics in essential hypertension","volume":"10","author":"Frohlich","year":"2008","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"10.1016\/j.mcna.2009.02.010_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archinte.141.1.81","article-title":"Obesity and essential hypertension: hemodynamics, intravascular volume, sodium excretion and plasma rennin activity","volume":"141","author":"Messerli","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2009.02.010_bib9","first-page":"280","article-title":"Hemodynamics in obesity","volume":"vol. 7","author":"Reisin","year":"1987"},{"issue":"1\u20132","key":"10.1016\/j.mcna.2009.02.010_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1006880708475","article-title":"Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension","volume":"188","author":"Zemel","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.mcna.2009.02.010_bib11","doi-asserted-by":"crossref","first-page":"E187","DOI":"10.1152\/ajpendo.1994.267.2.E187","article-title":"Hemodynamic actions of insulin","volume":"267","author":"Baron","year":"1994","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mcna.2009.02.010_bib12","first-page":"37","article-title":"Hypertension in obese subjects: distinct hypertensive subgroup","volume":"4","author":"Licata","year":"1990","journal-title":"J Hum Hypertens"},{"issue":"4 Pt 2","key":"10.1016\/j.mcna.2009.02.010_bib13","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.HYP.34.4.943","article-title":"State-of-the-art lecture: role of angiotensin and oxidative stress in essential hypertension","volume":"34","author":"Romero","year":"1999","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.mcna.2009.02.010_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.mcna.2009.02.010_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/01.RES.0000089255.37804.72","article-title":"The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes","volume":"93","author":"Rajapurohitam","year":"2003","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.mcna.2009.02.010_bib16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tcm.2007.06.001","article-title":"Leptin as a cardiac hypertrophic factor: a potential target for therapeutics","volume":"17","author":"Karmazyn","year":"2007","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.mcna.2009.02.010_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11906-008-0025-y","article-title":"Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease","volume":"10","author":"Patel","year":"2008","journal-title":"Curr Hypertens Rep"},{"issue":"5 Suppl","key":"10.1016\/j.mcna.2009.02.010_bib18","first-page":"62","article-title":"The heart in hypertension: a 1991 overview","volume":"18","author":"Frohlich","year":"1991","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.mcna.2009.02.010_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-99-6-757","article-title":"Dimorphic cardiac adaptation to obesity and arterial hypertension","volume":"99","author":"Messerli","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2009.02.010_bib20","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/archinte.1933.00160060085007","article-title":"Adiposity of the heart: a clinical pathologic study of 136 obese patients","volume":"52","author":"Smith","year":"1933","journal-title":"Arch Intern Med"},{"issue":"4\u20135","key":"10.1016\/j.mcna.2009.02.010_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000175819","article-title":"Left ventricular hypertrophy and mortality\u2014results from the Framingham Study","volume":"81","author":"Kannel","year":"1992","journal-title":"Cardiology"},{"issue":"8","key":"10.1016\/j.mcna.2009.02.010_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00004872-199008000-00012","article-title":"Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow Blood Pressure Clinic","volume":"8","author":"Dunn","year":"1990","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.mcna.2009.02.010_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1559-4572.2008.00003.x","article-title":"Obesity and dysrhythmias","volume":"3","author":"Anand","year":"2008","journal-title":"J Cardiometab Syndr"},{"issue":"3","key":"10.1016\/j.mcna.2009.02.010_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1559-4572.2008.00001.x","article-title":"Impact of obesity on the risk of heart failure and its prognosis","volume":"3","author":"Artham","year":"2008","journal-title":"J Cardiometab Syndr"},{"key":"10.1016\/j.mcna.2009.02.010_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in US adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann Intern Med"},{"issue":"11\u00a0Pt 1","key":"10.1016\/j.mcna.2009.02.010_bib26","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0895-7061(03)01009-4","article-title":"Association between microalbuminuria and the metabolic syndrome: NHANES III","volume":"16","author":"Palaniappan","year":"2003","journal-title":"Am J Hypertens"},{"issue":"7","key":"10.1016\/j.mcna.2009.02.010_bib27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.291.7.844","article-title":"Predictors of new-onset kidney disease in a community-based population","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mcna.2009.02.010_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0272-6386(12)70230-5","article-title":"Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia","volume":"20","author":"Verani","year":"1992","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.mcna.2009.02.010_bib29","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: an emerging epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int"},{"issue":"5 Pt 2","key":"10.1016\/j.mcna.2009.02.010_bib30","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1016\/S0895-7061(97)00075-7","article-title":"Mechanisms of abnormal renal sodium handling in obesity hypertension","volume":"10","author":"Hall","year":"1997","journal-title":"Am J Hypertens"},{"issue":"4","key":"10.1016\/j.mcna.2009.02.010_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00004872-198708000-00002","article-title":"Renal haemodynamic studies in obesity hypertension","volume":"5","author":"Reisin","year":"1987","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.mcna.2009.02.010_bib32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/01.HYP.26.4.610","article-title":"Combined renal effects of overweight and hypertension","volume":"26","author":"Ribstein","year":"1995","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib33","doi-asserted-by":"crossref","first-page":"F817","DOI":"10.1152\/ajprenal.2000.278.5.F817","article-title":"Glomerular hemodynamics in severe obesity","volume":"278","author":"Chagnac","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.mcna.2009.02.010_bib34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000441-200512000-00008","article-title":"Hypertension and the metabolic syndrome","volume":"330","author":"Morse","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.mcna.2009.02.010_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000095325","article-title":"Functional and structural renal changes in the early stages of obesity","volume":"151","author":"Thakur","year":"2006","journal-title":"Contrib Nephrol"},{"issue":"11","key":"10.1016\/j.mcna.2009.02.010_bib36","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1097\/01.ASN.0000141965.28037.EE","article-title":"Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?","volume":"15","author":"Bagby","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib37","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1046\/j.1523-1755.2002.00618.x","article-title":"Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage","volume":"62","author":"Kamijo","year":"2002","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.mcna.2009.02.010_bib38","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1210\/en.2003-0870","article-title":"Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome","volume":"144","author":"Unger","year":"2003","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.mcna.2009.02.010_bib39","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1097\/01.ASN.0000141966.69934.21","article-title":"The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity","volume":"15","author":"Wisse","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2009.02.010_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2002.29865","article-title":"Leptin and renal disease","volume":"39","author":"Wolf","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2009.02.010_bib41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000095328","article-title":"Leptin and renal fibrosis","volume":"151","author":"Wolf","year":"2006","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.mcna.2009.02.010_bib42","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0895-7061(00)01254-1","article-title":"Obesity-hypertension: the effects on cardiovascular and renal systems","volume":"13","author":"Zhang","year":"2000","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.mcna.2009.02.010_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11906-008-0027-9","article-title":"The treatment of hypertension in obese patients","volume":"10","author":"Wofford","year":"2008","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.mcna.2009.02.010_bib44","series-title":"Hypertension","first-page":"206","article-title":"Obesity-hypertension: effects on the cardiovascular and renal system\u2014the therapeutic approach","author":"Reisin","year":"1999"},{"issue":"19","key":"10.1016\/j.mcna.2009.02.010_bib45","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcna.2009.02.010_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM197801052980101","article-title":"Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients","volume":"298","author":"Reisin","year":"1978","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.mcna.2009.02.010_bib47","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0021-9681(82)90119-9","article-title":"Effects of weight reduction on arterial pressure","volume":"35","author":"Reisin","year":"1982","journal-title":"J Chronic Dis"},{"issue":"16","key":"10.1016\/j.mcna.2009.02.010_bib48","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group","volume":"336","author":"Appel","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2009.02.010_bib49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7326\/0003-4819-67-1-48","article-title":"The relation of adiposity to blood pressure and development of hypertension. The Framingham study","volume":"67","author":"Kannel","year":"1967","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mcna.2009.02.010_bib50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0002-8703(83)90289-2","article-title":"Nonpharmacologic therapy of hypertension: the independent effects of weight reduction and sodium restriction in overweight borderline hypertensive patients","volume":"105","author":"Gillum","year":"1983","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.mcna.2009.02.010_bib51","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/jama.279.11.839","article-title":"Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group","volume":"279","author":"Whelton","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2009.02.010_bib52","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jama.267.9.1213","article-title":"The effects of nonpharmacological interventions on blood pressure of persons with high normal levels. Results of the trial of hypertension prevention. Phase I","volume":"267","year":"1992","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcna.2009.02.010_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-134-1-200101020-00007","article-title":"Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II","volume":"134","author":"Stevens","year":"2001","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib54","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.mcna.2009.02.010_bib55","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/HYPERTENSIONAHA.106.085944","article-title":"Dietary therapy for obesity: an emperor with no clothes","volume":"51","author":"Mark","year":"2008","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.mcna.2009.02.010_bib56","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.ijo.0803769","article-title":"Weight maintenance, behaviors and barriers among previous participants of a university-based weight control program","volume":"32","author":"Befort","year":"2008","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"10.1016\/j.mcna.2009.02.010_bib57","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/HYPERTENSIONAHA.107.094011","article-title":"Weight loss and blood pressure control (Pro)","volume":"51","author":"Harsha","year":"2008","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.mcna.2009.02.010_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0002-9343(78)90045-1","article-title":"The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension","volume":"64","author":"Kawasaki","year":"1978","journal-title":"Am J Med"},{"issue":"3 Pt 2","key":"10.1016\/j.mcna.2009.02.010_bib59","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.27.3.481","article-title":"Salt sensitivity of blood pressure in humans","volume":"27","author":"Weinberger","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2009.02.010_bib60","series-title":"Hypertension primer. The essentials of high blood pressure. Basic science, population science, and clinical management","first-page":"156","article-title":"Salt sensitivity","author":"Elijovich","year":"2008"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib61","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1751-7176.2008.07609.x","article-title":"Salt-resistant and salt-sensitive phenotypes determine the sensitivity of blood pressure to weight loss in overweight\/obese patients","volume":"10","author":"Hoffmann","year":"2008","journal-title":"J Clin Hypertens"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2009.02.010_bib62","article-title":"National Heart, Lung, and Blood Institutes. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2014the evidence report","volume":"6","author":"National Institutes of Health","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.mcna.2009.02.010_bib63","series-title":"Hypertension pathophysiology, diagnosis and management","first-page":"1985","article-title":"Physical exercise in hypertension","author":"Fagard","year":"1990"},{"issue":"1","key":"10.1016\/j.mcna.2009.02.010_bib64","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCULATIONAHA.106.176158","article-title":"Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee","volume":"114","author":"American Heart Association Nutrition Committee","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mcna.2009.02.010_bib65","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.ijo.0803781","article-title":"The effects of high-intensity intermittent exercise training on fat loss and fasting insulin levels of young women","volume":"32","author":"Trapp","year":"2008","journal-title":"Int J\u00a0Obes (Lond)"},{"issue":"21","key":"10.1016\/j.mcna.2009.02.010_bib66","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJM197705262962103","article-title":"Alcohol consumption and blood pressure Kaiser-Permanente Multiphasic Health Examination data","volume":"296","author":"Klatsky","year":"1977","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.mcna.2009.02.010_bib67","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archinte.143.7.1366","article-title":"Drinking and its relation to smoking, BP, blood lipids, and uric acid. The Framingham study","volume":"143","author":"Gordon","year":"1983","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib68","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/01.HYP.0000164627.01274.ec","article-title":"Vascular effects of alcoholic beverages: is it only alcohol that matters?","volume":"45","author":"Fuchs","year":"2005","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.mcna.2009.02.010_bib69","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.HYP.20.4.533","article-title":"Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweight men","volume":"20","author":"Puddey","year":"1992","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.mcna.2009.02.010_bib70","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.HYP.16.4.398","article-title":"Two-way factorial study of alcohol and salt restriction in treated hypertensive men","volume":"16","author":"Parker","year":"1990","journal-title":"Hypertension"},{"issue":"50","key":"10.1016\/j.mcna.2009.02.010_bib71","first-page":"307","article-title":"Alcohol and hypertension: a review","volume":"2","author":"Klatsky","year":"2008","journal-title":"J Agric Saf Health"},{"issue":"6","key":"10.1016\/j.mcna.2009.02.010_bib72","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib73","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.ATV.0000216787.85457.f3","article-title":"Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss","volume":"26","author":"Poirier","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.mcna.2009.02.010_bib74","series-title":"Hypertension, pathophysiology, diagnosis and management","first-page":"2683","article-title":"Obesity-hypertension: non pharmacologic and pharmacologic therapeutic modalities","author":"Reisin","year":"1955"},{"issue":"3","key":"10.1016\/j.mcna.2009.02.010_bib75","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-98-3-315","article-title":"Cardiovascular changes after weight reduction in obesity hypertension","volume":"98","author":"Reisin","year":"1983","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2009.02.010_bib76","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/HJH.0b013e3280115bfb","article-title":"Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study","volume":"25","author":"Ikonomidis","year":"2007","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.mcna.2009.02.010_bib77","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/HYPERTENSIONAHA.108.111427","article-title":"Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight\/obese adults","volume":"52","author":"Pierce","year":"2008","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.mcna.2009.02.010_bib78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1523-1755.2001.00463.x","article-title":"Effects of dehydroepiandrosterone and quinapril on nephropathy in obese Zucker rats","volume":"59","author":"Richards","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2009.02.010_bib79","first-page":"823","article-title":"Effects of a modified low calorie diet in metabolic changes and kidney histology in young obese Zucker rats","volume":"18","author":"Liao","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.mcna.2009.02.010_bib80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000188541","article-title":"Effects of body-weight loss and captopril treatment on proteinuria associated with obesity","volume":"70","author":"Praga","year":"1995","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.mcna.2009.02.010_bib81","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/ajkd.2003.50039","article-title":"Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies","volume":"41","author":"Morales","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.mcna.2009.02.010_bib82","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/01.ASN.0000068462.38661.89","article-title":"The effects of weight loss on renal function in patients with severe obesity","volume":"14","author":"Chagnac","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2009.02.010_bib83","first-page":"S23","article-title":"Obesity-associated hypertension: hypothesized link between etiology and selection of therapy","volume":"4","author":"Reisin","year":"1999","journal-title":"Blood Press Monit"},{"issue":"6","key":"10.1016\/j.mcna.2009.02.010_bib84","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1 Pt 1","key":"10.1016\/j.mcna.2009.02.010_bib85","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/01.HYP.30.1.140","article-title":"Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group","volume":"30","author":"Reisin","year":"1997","journal-title":"Hypertension"},{"issue":"8 Pt 1","key":"10.1016\/j.mcna.2009.02.010_bib86","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0895-7061(98)00087-9","article-title":"Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group","volume":"11","author":"Weir","year":"1998","journal-title":"Am J Hypertens"},{"issue":"12","key":"10.1016\/j.mcna.2009.02.010_bib87","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.2337\/dc06-1373","article-title":"Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome","volume":"29","author":"Bakris","year":"2006","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib88","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR gamma-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.mcna.2009.02.010_bib89","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/oby.2005.235","article-title":"Effects of irbesartan on the growth and differentiation of adipocytes in obese Zucker rats","volume":"13","author":"Di Filippo","year":"2005","journal-title":"Obes Res"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib90","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/HYPERTENSIONAHA.106.084301","article-title":"Direct renin inhibition with aliskiren in obese patients with arterial hypertension","volume":"49","author":"Jordan","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2009.02.010_bib91","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/01.CIR.20.6.1028","article-title":"Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide","volume":"20","author":"Wilson","year":"1959","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mcna.2009.02.010_bib92","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00004872-198604000-00015","article-title":"The effects of thiazide diuretics upon plasma lipoproteins","volume":"4","author":"Johnson","year":"1986","journal-title":"J Hypertens"},{"issue":"13","key":"10.1016\/j.mcna.2009.02.010_bib93","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJM198909283211305","article-title":"A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension","volume":"321","author":"Pollare","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mcna.2009.02.010_bib94","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1097\/HJH.0b013e328302ca38","article-title":"The metabolic syndrome in hypertension: European Society of Hypertension position statement","volume":"26","author":"Redon","year":"2008","journal-title":"J Hypertens"},{"issue":"Suppl 3","key":"10.1016\/j.mcna.2009.02.010_bib95","first-page":"S59","article-title":"Obesity-related hypertension: its physiological basis and pharmacological approaches to its treatment","volume":"10","author":"Richards","year":"1996","journal-title":"J Hum Hypertens"},{"issue":"12 Pt 2","key":"10.1016\/j.mcna.2009.02.010_bib96","doi-asserted-by":"crossref","first-page":"333S","DOI":"10.1093\/ajh\/3.10.333","article-title":"Endocrine and renal effects of nifedipine gastrointestinal therapeutic system in patients with essential hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension Study Group","volume":"3","author":"Tuck","year":"1990","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1016\/j.mcna.2009.02.010_bib97","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1523-1755.2004.00620.x","article-title":"Differential effects of calcium antagonist subclasses on markers of nephropathy progression","volume":"65","author":"Bakris","year":"2004","journal-title":"Kidney Int"},{"issue":"7 Pt 1","key":"10.1016\/j.mcna.2009.02.010_bib98","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0895-7061(01)01293-6","article-title":"Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects","volume":"14","author":"Wofford","year":"2001","journal-title":"Am J\u00a0Hypertens"},{"issue":"15","key":"10.1016\/j.mcna.2009.02.010_bib99","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"283","year":"2000","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1440-1681.1987.tb00999.x","article-title":"Clonidine: understanding its disposition, sites and mechanism of action","volume":"14","author":"Jarrott","year":"1987","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib101","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00004872-199205000-00013","article-title":"The treatment of obese hypertensive black women: a comparative study of chlorthalidone versus clonidine","volume":"10","author":"Reisin","year":"1992","journal-title":"J Hypertens"},{"issue":"1 Suppl","key":"10.1016\/j.mcna.2009.02.010_bib102","doi-asserted-by":"crossref","first-page":"I67","DOI":"10.1161\/01.HYP.19.1_Suppl.I67","article-title":"Obesity, the sympathetic nervous system, and essential hypertension","volume":"19","author":"Tuck","year":"1992","journal-title":"Hypertension"},{"issue":"11\u00a0Pt 2","key":"10.1016\/j.mcna.2009.02.010_bib103","doi-asserted-by":"crossref","first-page":"303S","DOI":"10.1093\/ajh\/6.11.303S","article-title":"Hypertension and hyperlipidemia. A review","volume":"6","author":"Lithell","year":"1993","journal-title":"Am J Hypertens"},{"issue":"13","key":"10.1016\/j.mcna.2009.02.010_bib104","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200003303421301","article-title":"Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study","volume":"342","author":"Gress","year":"2000","journal-title":"N Engl J Med"},{"issue":"8440","key":"10.1016\/j.mcna.2009.02.010_bib105","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(85)92310-4","article-title":"Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients","volume":"1","author":"MacMahon","year":"1985","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib106","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00004872-199105000-00007","article-title":"Cardiovascular effects of weight reduction versus antihypertensive drug treatment: a comparative, randomized, 1-year study of obese men with mild hypertension","volume":"9","author":"Fagerberg","year":"1991","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib107","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1524-6175.2005.04679.x","article-title":"Do the metabolic effects of beta blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?","volume":"8","author":"Sarafidis","year":"2006","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"5","key":"10.1016\/j.mcna.2009.02.010_bib108","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/sleep\/19.5.388","article-title":"Hemodynamic consequences of obstructive sleep apnea","volume":"19","author":"Weiss","year":"1996","journal-title":"Sleep"},{"issue":"15","key":"10.1016\/j.mcna.2009.02.010_bib109","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.106.625400","article-title":"Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study","volume":"115","author":"Scholze","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.mcna.2009.02.010_bib110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-142-7-200504050-00011","article-title":"Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians","volume":"142","author":"Snow","year":"2005","journal-title":"Ann Intern Med"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571250900025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571250900025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T23:13:41Z","timestamp":1558307621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571250900025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":110,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S002571250900025X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2009.02.010","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}